TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 429,000 Value ($000) $371 Avg Close — Range —
Q2 2024
Shares 602,000 Value ($000) $392 Avg Close — Range —
Q1 2022
Shares 6,213,000 Value ($000) $6,614 Avg Close — Range —